International Validation Study Of The Algoplus Scale In Five Languages

NCT02018614 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2014-07-08

No results posted yet for this study

Summary

Acute pain is responsible for unnecessary suffering. Among elderly patients, acute pain is frequent and underestimated, especially when these patients have cognitive disorders. The expression of pain is then modified and the conventional tools for evaluating pain cannot be used. Thus the existence of pain must be detected on the basis of a behavioural assessment.

It is nonetheless necessary to have the assistance of standardised and validated tools. In France, the Doloplus Group has proposed a scale called Doloplus, validated in January 1999, and is now proposing a new scale for acute pain, Algoplus that has been validated in French (4). Doloplus has been recently translated and validated in 5 languages and an identical methodology will be used in this protocol.

Internationally, although several teams are working on the development of scales that can be used for non-communicating elderly subjects, there is as yet no validated tool for acute pain assessment.

Considering 1- the lack of tools at an international level and 2- the frequent request from many practitioners worldwide, the Doloplus group has offered to validate the Algoplus® scale in 5 foreign languages, English, German, Spanish, Italian, Portuguese. A rigorous methodology with the help of a statistician will be used in this validation process.

Conditions

  • Pain
  • Elderly
  • Communication Disorders

Interventions

OTHER

algoplus

Sponsors & Collaborators

  • Dr M Fisher Dr. Ulrike Bornschlegel

    collaborator UNKNOWN
  • Dr M Schuler

    collaborator UNKNOWN
  • Dr Pat Schofield

    collaborator UNKNOWN
  • Dr D Lussier

    collaborator UNKNOWN
  • Dr S Gibson

    collaborator UNKNOWN
  • Dr Joan ESPAULELLA PANICOT

    collaborator UNKNOWN
  • Dr Joan Manuel PEREZ CASTEJON

    collaborator UNKNOWN
  • Gambassi, Giovanni, M.D.

    collaborator INDIV
  • Dr Patrizio ODETTI

    collaborator UNKNOWN
  • Dr Fiametta MONACELLI

    collaborator UNKNOWN
  • University Hospital, Grenoble

    collaborator OTHER
  • Dr Hirondina GUARDA, Dr Sónia SANTOS

    collaborator UNKNOWN
  • Dr Gisèle PICKERING

    collaborator UNKNOWN
  • Dr Valérie LEGOUT

    collaborator UNKNOWN
  • Dr Patrice Rat

    collaborator UNKNOWN
  • Dr Bernard WARY

    collaborator UNKNOWN
  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Gisèle PICKERING · CHU de Clermont-Ferrand

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-10-31
Completion
2015-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02018614 on ClinicalTrials.gov